ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 172,51
-0,14%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Valeritas Holdings Inc (VLRX)

  7. Valeritas Holdings Inc (VLRX) Actualités

VLRX

Valeritas (VLRX)

Valeritas Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VLRX
DateHeureSourceTitreSymboleSociété
15/02/202000h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VLRXValeritas Holdings Inc
14/02/202016h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VLRXValeritas Holdings Inc
10/02/202002h21PR Newswire (US)Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain EmployeesNASDAQ:VLRXValeritas Holdings Inc
23/01/202022h36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VLRXValeritas Holdings Inc
23/12/201923h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VLRXValeritas Holdings Inc
20/12/201914h45GlobeNewswire Inc.Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...NASDAQ:VLRXValeritas Holdings Inc
09/12/201913h00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...NASDAQ:VLRXValeritas Holdings Inc
15/11/201913h00GlobeNewswire Inc.Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin UsageNASDAQ:VLRXValeritas Holdings Inc
12/11/201923h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VLRXValeritas Holdings Inc
12/11/201922h05GlobeNewswire Inc.Valeritas Announces Third Quarter 2019 Financial ResultsNASDAQ:VLRXValeritas Holdings Inc
29/10/201912h00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)NASDAQ:VLRXValeritas Holdings Inc
24/10/201913h00GlobeNewswire Inc.Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019NASDAQ:VLRXValeritas Holdings Inc
21/10/201913h00GlobeNewswire Inc.GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...NASDAQ:VLRXValeritas Holdings Inc
15/10/201913h00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...NASDAQ:VLRXValeritas Holdings Inc
10/10/201913h00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...NASDAQ:VLRXValeritas Holdings Inc
08/10/201913h00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the World Congress of Neurology (WCN 2...NASDAQ:VLRXValeritas Holdings Inc
04/10/201922h13Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:VLRXValeritas Holdings Inc
03/10/201913h00GlobeNewswire Inc.Valeritas Hosts Educational Symposium and Participates in the Metabolic & Endocrine Disease Summit (MEDS) EastNASDAQ:VLRXValeritas Holdings Inc
02/10/201923h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VLRXValeritas Holdings Inc
02/10/201913h00GlobeNewswire Inc.Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Prefe...NASDAQ:VLRXValeritas Holdings Inc
26/09/201915h31GlobeNewswire Inc.Valeritas Announces Participation on “The Cutting Edge of Cannabinoid Science” Panel at the CBD Expo EAST ConferenceNASDAQ:VLRXValeritas Holdings Inc
24/09/201913h00GlobeNewswire Inc.Valeritas Presents Positive h-Patch™ CBD Study Data at CannMed ConferenceNASDAQ:VLRXValeritas Holdings Inc
19/09/201913h00GlobeNewswire Inc.Valeritas Announces Presentation of Preclinical h-Patch™ CBD Study at CannMed ConferenceNASDAQ:VLRXValeritas Holdings Inc
17/09/201913h00GlobeNewswire Inc.Valeritas Announces Poster Presentation of Preclinical h-Patch™ Apomorphine Study at the Global Experts Meeting on Frontier...NASDAQ:VLRXValeritas Holdings Inc
12/09/201913h00GlobeNewswire Inc.Valeritas Presents Positive CBD h-Patch™ Data at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals SummitNASDAQ:VLRXValeritas Holdings Inc
10/09/201912h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VLRXValeritas Holdings Inc
05/09/201922h07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:VLRXValeritas Holdings Inc
03/09/201913h00GlobeNewswire Inc.Valeritas Announces Oral Presentation of Preclinical h-Patch™ CBD Study at the 2nd Annual International Cannabinoid-Derived...NASDAQ:VLRXValeritas Holdings Inc
29/08/201922h05GlobeNewswire Inc.Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:VLRXValeritas Holdings Inc
15/08/201913h00GlobeNewswire Inc.Clinical Trial Evaluating Delivery of Regular Human Insulin vs. Rapid Acting Insulin Delivered by Valeritas’ V-Go® Meets P...NASDAQ:VLRXValeritas Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:VLRX

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
VIV
Vivendi
EU
HO
Thales
NASDAQ
AMZN
Amazon.com
EU
CS
Axa
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
EU
SGO
Cie de SaintGobain
EU
ORA
Orange
EU
ML
Michelin
EU
AI
Air Liquide
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés